Drugs / CDVAX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02991417 | Jan → Mar 2017 | Clostridium infectious disease | Simon M. Cutting | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CDVAX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02991417 ↗ |
| Modality | Vaccine | “Clostridium difficile vaccine (CDVAX)” NCT02991417 ↗ |
| Route | Oral | “Oral Vaccination Against Clostridium Difficile Infection” NCT02991417 ↗ |